27 Recruiting Acute Myeloid Leukemia (AML) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Acute Myeloid Leukemia (AML)
Related Conditions
Top Recruiting Acute Myeloid Leukemia (AML) Studies
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
📍 City of Hope /ID# 154105 — Duarte, California
View Study & Checklist ➔A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
📍 City of Hope Nat'l Medical Center — Duarte, California
View Study & Checklist ➔Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
📍 UT MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
📍 Houston Methodist Neal Cancer Center — Houston, Texas
View Study & Checklist ➔Improving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid Leukemia
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
📍 UCLA Medical Center — Los Angeles, California
View Study & Checklist ➔Niclosamide in Pediatric Patients With Relapsed and Refractory AML
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
📍 Colorado Blood Cancer Institute — Denver, Colorado
View Study & Checklist ➔CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
📍 Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Caris Chromoseq Data Collection
📍 Caris Life Sciences — Phoenix, Arizona
View Study & Checklist ➔Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔